SunWay Biotech Co (ROCO:1271) Construction In Progress: NT$243.2 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1271 SunWay Biotech Co Ltd ROCO:1271
90 GF Score
Price NT$61.00
GF Value NT$71.11
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is SunWay Biotech Co Construction In Progress?

SunWay Biotech Co ROCO:1271 -4.39% 90 Construction In Progress is NT$243.2 Mil as of Dec. 2025. GuruFocus rates ROCO:1271 with a GF Score™ of 90/100 and a GF Value™ of NT$71.11 (Modestly Undervalued). The stock has 7 warning signs investors should review.

SunWay Biotech Co's quarterly construction in progress increased from Dec. 2024 (NT$171.2 Mil) to Jun. 2025 (NT$205.9 Mil) and increased from Jun. 2025 (NT$205.9 Mil) to Dec. 2025 (NT$243.2 Mil).

SunWay Biotech Co's annual construction in progress increased from Dec. 2023 (NT$114.6 Mil) to Dec. 2024 (NT$171.2 Mil) and increased from Dec. 2024 (NT$171.2 Mil) to Dec. 2025 (NT$243.2 Mil).

SunWay Biotech Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for SunWay Biotech Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SunWay Biotech Co Construction In Progress Chart

SunWay Biotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial 0.00 0.00 114.63 171.21 243.24

SunWay Biotech Co Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114.63 157.20 171.21 205.92 243.24
ROCO:1271
90GF Score
SunWay Biotech Co Ltd ROCO:1271
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SunWay Biotech Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of NT$243.2 Mil mean?
SunWay Biotech Co (ROCO:1271) has a Construction In Progress of NT$243.2 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on SunWay Biotech Co and its competitors.
Is SunWay Biotech Co's Construction In Progress too high?
SunWay Biotech Co's current Construction In Progress is NT$243.2 Mil. Overall, SunWay Biotech Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SunWay Biotech Co's Construction In Progress compare to KHC and GIS?
SunWay Biotech Co's Construction In Progress of NT$243.2 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Consumer Packaged Goods company?
A good Construction In Progress depends on the Consumer Packaged Goods industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on SunWay Biotech Co and its competitors. SunWay Biotech Co's current Construction In Progress is NT$243.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SunWay Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, SunWay Biotech Co (ROCO:1271) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$71.11, compared to a current price of NT$61.00 — trading 14.2% below its estimated fair value. The current Construction In Progress is NT$243.2 Mil. SunWay Biotech Co's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For SunWay Biotech Co (ROCO:1271), the current Construction In Progress is NT$243.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SunWay Biotech Co (ROCO:1271) Overvalued in 2026?

Based on GuruFocus' analysis, SunWay Biotech Co stock appears to be undervalued. The current stock price of NT$61.00 is trading 14.2% below its estimated GF Value™ of NT$71.11. GuruFocus considers SunWay Biotech Co to be Modestly Undervalued.

Key valuation signals for ROCO:1271:

  • Construction In Progress: NT$243.2 Mil
  • GF Value™: NT$71.11 vs. price of NT$61.00 (14.2% below fair value)
  • GF Score™: 90/100 with 7 warning signs

No single metric tells the full story. See the ROCO:1271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SunWay Biotech Co Business Description

Address No. 139, Xing’ai Road, Neihu District, Taipei, TWN, 11494
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
90GF Score

Get the complete analysis for ROCO:1271

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$61.00
Price
NT$71.11
GF Value